Literature DB >> 25520048

Pleiotropic actions of iron balance in diabetes mellitus.

Xinhui Wang1, Xuexian Fang, Fudi Wang.   

Abstract

As an essential element, iron plays a central role in many physiological processes, including redox balance, inflammation, energy metabolism, and environment sensing. Perturbations in iron homeostasis are associated with several conditions, including hyperglycemia and diabetes, both of which have been studied in patients and animal models. To clarify the pleiotropic role of iron homeostasis in diabetes development, the early studies on diseases with iron-overload, studies on clinical iron depletion therapies, associations between iron-related genetic polymorphisms and diabetes, and etiological mechanisms underlying iron perturbations-impaired insulin secretion and insulin sensitivity were carefully reviewed and discussed. Hereditary hemochromatosis, transfusion-dependent thalassemia, and excess heme iron intake can increase the risk of developing diabetes. Genetically modified mice and mice fed a high-iron diet present with discrepant phenotypes due to differences in tissue iron distribution. Moreover, several genetic polymorphisms related to iron homeostasis have been associated with the risk of developing diabetes. Tightly controlled iron metabolism is essential for insulin secretion and insulin sensitivity, and iron overload in pancreatic islets alters reactive oxygen species (ROS) generation, as well as hypoxia-inducible factor-1α (HIF-1α) stability and adenosine triphosphate (ATP) synthesis, thereby impairing the function and viability of β-cells. Decreased levels of adiponectin, macrophage-mediated inflammation, and ROS-mediated liver kinase B1 (LKB1)/adenosine monophosphate-activated protein kinase (AMPK) activation can contribute to iron overload-induced insulin resistance, whereas iron deficiency could also participate in obesity-related inflammation, hypoxia, and insulin resistance. Because iron homeostasis is closely correlated with many metabolic processes, future studies are needed in order to elucidate the finely tuned network among iron homeostasis, carbohydrate and lipid metabolism, inflammation, and hypoxia.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25520048     DOI: 10.1007/s11154-014-9303-y

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  93 in total

1.  HFE genetic variability, body iron stores, and the risk of type 2 diabetes in U.S. women.

Authors:  Lu Qi; James Meigs; JoAnn E Manson; Jing Ma; David Hunter; Nader Rifai; Frank B Hu
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

2.  Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.

Authors:  Ernest Beutler; Vincent J Felitti; James A Koziol; Ngoc J Ho; Terri Gelbart
Journal:  Lancet       Date:  2002-01-19       Impact factor: 79.321

Review 3.  Iron overload and glucose metabolism in subjects with β-thalassaemia major: an overview.

Authors:  Vincenzo De Sanctis; Ashraf Soliman; Mohamed Yassin
Journal:  Curr Diabetes Rev       Date:  2013-07

4.  Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals.

Authors:  David Patsouris; Ping-Ping Li; Divya Thapar; Justin Chapman; Jerrold M Olefsky; Jaap G Neels
Journal:  Cell Metab       Date:  2008-10       Impact factor: 27.287

5.  Differential regulation of human ALAS1 mRNA and protein levels by heme and cobalt protoporphyrin.

Authors:  Jianyu Zheng; Ying Shan; Richard W Lambrecht; Susan E Donohue; Herbert L Bonkovsky
Journal:  Mol Cell Biochem       Date:  2008-08-22       Impact factor: 3.396

Review 6.  Diabetes mellitus and the β cell: the last ten years.

Authors:  Frances M Ashcroft; Patrik Rorsman
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

Review 7.  Body iron stores and heme-iron intake in relation to risk of type 2 diabetes: a systematic review and meta-analysis.

Authors:  Zhuoxian Zhao; Sheyu Li; Guanjian Liu; Fangfang Yan; Xuelei Ma; Zeyu Huang; Haoming Tian
Journal:  PLoS One       Date:  2012-07-26       Impact factor: 3.240

8.  The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin.

Authors:  Laura Silvestri; Alessia Pagani; Antonella Nai; Ivana De Domenico; Jerry Kaplan; Clara Camaschella
Journal:  Cell Metab       Date:  2008-10-30       Impact factor: 27.287

9.  A CASE OF HAEMOCHROMATOSIS.-THE RELATION OF HAEMOCHROMATOSIS TO BRONZED DIABETES.

Authors:  E L Opie
Journal:  J Exp Med       Date:  1899-05-01       Impact factor: 14.307

10.  Association between serum ferritin and osteocalcin as a potential mechanism explaining the iron-induced insulin resistance.

Authors:  Martí Juanola-Falgarona; José Cándido-Fernández; Jordi Salas-Salvadó; Miguel A Martínez-González; Ramón Estruch; Miquel Fiol; Victoria Arija-Val
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

View more
  17 in total

1.  Diabetes Mellitus in Thalassaemia Major Patients: A Report from the Southeast of Iran.

Authors:  Ali Bazi; Javad Sharifi-Rad; Daryoush Rostami; Omolbanin Sargazi-Aval; Amin Safa
Journal:  J Clin Diagn Res       Date:  2017-05-01

2.  Dietary Meat, Trimethylamine N-Oxide-Related Metabolites, and Incident Cardiovascular Disease Among Older Adults: The Cardiovascular Health Study.

Authors:  Meng Wang; Zeneng Wang; Stanley L Hazen; Dariush Mozaffarian; Yujin Lee; Heidi T M Lai; Marcia C de Oliveira Otto; Rozenn N Lemaitre; Amanda Fretts; Nona Sotoodehnia; Matthew Budoff; Joseph A DiDonato; Barbara McKnight; W H Wilson Tang; Bruce M Psaty; David S Siscovick
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-08-01       Impact factor: 10.514

3.  Hepcidin and iron metabolism in non-diabetic obese and type 2 diabetic rats.

Authors:  Yue Chen; Hui-Qing Yin; Hao-Ling Liu; Lei Xiu; Xiao-Yu Peng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-12-16

4.  Increased intracellular iron in mouse primary hepatocytes in vitro causes activation of the Akt pathway but decreases its response to insulin.

Authors:  Joe Varghese; Jithu James; Sophie Vaulont; Andrew Mckie; Molly Jacob
Journal:  Biochim Biophys Acta Gen Subj       Date:  2018-05-31       Impact factor: 3.770

5.  Identification of Risk Factors Affecting Impaired Fasting Glucose and Diabetes in Adult Patients from Northeast China.

Authors:  Yutian Yin; Weiqing Han; Yuhan Wang; Yue Zhang; Shili Wu; Huiping Zhang; Lingling Jiang; Rui Wang; Peng Zhang; Yaqin Yu; Bo Li
Journal:  Int J Environ Res Public Health       Date:  2015-10-12       Impact factor: 3.390

6.  Heme Oxygenase Induction Suppresses Hepatic Hepcidin and Rescues Ferroportin and Ferritin Expression in Obese Mice.

Authors:  Nitin Puri; Yevgeniy Arefiev; Robert Chao; David Sacerdoti; Hibba Chaudry; Alexandra Nichols; Krithika Srikanthan; Athar Nawab; Dana Sharma; Vishal Hari Lakhani; Rebecca Klug; Komal Sodhi; Stephen J Peterson
Journal:  J Nutr Metab       Date:  2017-09-14

7.  Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol.

Authors:  Christoph Schindler; Andreas L Birkenfeld; Markolf Hanefeld; Ulrike Schatz; Carsta Köhler; Martin Grüneberg; Diethelm Tschöpe; Matthias Blüher; Christoph Hasslacher; Stefan R Bornstein
Journal:  Diabetes Ther       Date:  2017-11-13       Impact factor: 2.945

8.  Iron affects Ire1 clustering propensity and the amplitude of endoplasmic reticulum stress signaling.

Authors:  Nir Cohen; Michal Breker; Anush Bakunts; Kristina Pesek; Ainara Chas; Josepmaria Argemí; Andrea Orsi; Lihi Gal; Silvia Chuartzman; Yoav Wigelman; Felix Jonas; Peter Walter; Robert Ernst; Tomás Aragón; Eelco van Anken; Maya Schuldiner
Journal:  J Cell Sci       Date:  2017-08-09       Impact factor: 5.285

Review 9.  Iron deficiency as energetic insult to skeletal muscle in chronic diseases.

Authors:  Magdalena Dziegala; Krystian Josiak; Monika Kasztura; Kamil Kobak; Stephan von Haehling; Waldemar Banasiak; Stefan D Anker; Piotr Ponikowski; Ewa Jankowska
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-09-04       Impact factor: 12.910

10.  The Loss of Myocardial Benefit following Ischemic Preconditioning Is Associated with Dysregulation of Iron Homeostasis in Diet-Induced Diabetes.

Authors:  Vladimir Vinokur; Sarah Weksler-Zangen; Eduard Berenshtein; Ron Eliashar; Mordechai Chevion
Journal:  PLoS One       Date:  2016-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.